SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-20-006219
Filing Date
2020-06-02
Accepted
2020-06-02 08:33:23
Documents
18
Period of Report
2020-05-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tenx_8k.htm 8-K 28548
2 PRESS RELEASE tenx_ex991.htm EX-99.1 22335
3 PRESENTATION tenx_ex992.htm EX-99.2 13062
4 IMAGE tenax.jpg GRAPHIC 6389
5 IMAGE tenx_ex992000.jpg GRAPHIC 54783
6 IMAGE tenx_ex992001.jpg GRAPHIC 65295
7 IMAGE tenx_ex992002.jpg GRAPHIC 79067
8 IMAGE tenx_ex992003.jpg GRAPHIC 59105
9 IMAGE tenx_ex992004.jpg GRAPHIC 106513
10 IMAGE tenx_ex992005.jpg GRAPHIC 55798
11 IMAGE tenx_ex992006.jpg GRAPHIC 93946
12 IMAGE tenx_ex992007.jpg GRAPHIC 64059
13 IMAGE tenx_ex992008.jpg GRAPHIC 60273
14 IMAGE tenx_ex992009.jpg GRAPHIC 50445
15 IMAGE tenx_ex992010.jpg GRAPHIC 76188
16 IMAGE tenx_ex992011.jpg GRAPHIC 76288
17 IMAGE tenx_ex992012.jpg GRAPHIC 78013
18 IMAGE tenx_ex992013.jpg GRAPHIC 143144
  Complete submission text file 0001654954-20-006219.txt   1539506
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34600 | Film No.: 20935645
SIC: 8731 Services-Commercial Physical & Biological Research